Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results

Blood (2013) 121 (13): 2415–2423.

https://doi.org/10.1182/blood-2012-06-437681

Published: 2013

Includes: Supplemental data

Journal Articles

Low CNS Relapse Incidence without Radiotherapy and Improvement of Outcome: Results of Subsequent EORTC-CLG 58881 and 58951 Trials in Pediatric T-Cell Acute Lymphoblastic Leukemia (ALL)

Blood (2012) 120 (21): 133.

https://doi.org/10.1182/blood.V120.21.133.133

Published: 2012

Journal Articles

Prolonged E. Coli Asparaginase Therapy Does Not Improve Significantly the Outcome for Children with Low and Average Risk Acute Lymphoblastic Leukemia (ALL) and Non Hodgkin Lymphoma (NHL): Final Report of the EORTC-CLG Randomized Phase III Trial 58951

Blood (2012) 120 (21): 134.

https://doi.org/10.1182/blood.V120.21.134.134

Published: 2012

Journal Articles

In Childhood B-Lineage Acute Lymphoblastic Leukemia (B-ALL) with Hyperdiploidy >50 Chromosomes, Patients with 58 to 66 Chromosomes Have 99% EFS At 6-Year Follow-up: Results of the EORTC CLG 58951 Trial

Blood (2011) 118 (21): 565.

https://doi.org/10.1182/blood.V118.21.565.565

Published: 2011

Journal Articles

Similar Efficacy and Toxicity Profile for Idarubicine and Mitoxantrone in Induction and Intensification Treatment of Children with Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS): Long-Term Results of the EORTC-CLG Randomized Phase III Trial 58921

Barbara De Moerloose, Stefan Suciu, Martine Munzer, Caroline Piette, Karima Yakouben, Genevieve Margueritte, Patrick Lutz, Anne Uyttebroeck, Pierre Rohrlich, MD, PhD, Alina Ferster, Patrick Boutard, Marie-Françoise Dresse, Xavier Rialland, Lucilia Norton, Nicolas Sirvent, Matthias Karrasch, Yves Benoit, MD, Yves Bertrand

Blood (2011) 118 (21): 2615.

https://doi.org/10.1182/blood.V118.21.2615.2615

Published: 2011

Journal Articles

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951

Blood (2010) 116 (1): 36–44.

https://doi.org/10.1182/blood-2009-10-247965

Published: 2010

Includes: Supplemental data

Journal Articles

Prognostic Significance of NOTCH1 and FBXW7 Mutations in Childhood T-Cell Acute Lymphoblastic Leukemia (T-ALL): Results From the EORTC Children Leukemia Group.

Blood (2009) 114 (22): 909.

https://doi.org/10.1182/blood.V114.22.909.909

Published: 2009

Journal Articles

Dexamethasone(DEX)(6mg/sm/d) and Prednisolone(PRED)(60mg/sm/d) in Induction Therapy of Childhood ALL Are Equally Effective: Results of the 2nd Interim Analysis of EORTC Trial 58951

Blood (2008) 112 (11): 8.

https://doi.org/10.1182/blood.V112.11.8.8

Published: 2008

Journal Articles

Prognostic Significance of Central Nervous System (CNS) Status of Children with Acute Lymphoblastic Leukemia (ALL) Treated without Cranial Irradiation: Results of European Organization for Research and Treatment of Cancer (EORTC) Children Leukemia Group Study 58951

Blood (2008) 112 (11): 303.

https://doi.org/10.1182/blood.V112.11.303.303

Published: 2008

Journal Articles

Improved Outcome with Pulses of Vincristine and Steroids in Continuation Therapy of Children with Average Risk Acute Lymphoblastic Leukemia (ALL) and Non Hodgkin Lymphoma (NHL): Final Report of the EORTC Randomized Phase III Trial 58951

Blood (2008) 112 (11): 11.

https://doi.org/10.1182/blood.V112.11.11.11

Published: 2008

Journal Articles

Efficacy of the Combination of Gemtuzumab-Ozogamicin (Mylotarg(R)) and Cytarabine (GOCYT) in Childhood Myeloid Leukemia: A Compassionate Use Based Review in France.

Benoit Brethon, MD, Karima Yakouben, MD, Caroline Oudot, MD, Patrick Boutard, MD, Benedicte Bruno, MD, Cecile Jerome, MD, Brigitte Nelken, MD, Lionel de Lumley, MD, Yves Bertrand, MD, Jean-Hugues Dalle, MD,PhD, Thierry Leblanc, MD, Andre Baruchel, MD

Blood (2006) 108 (11): 2015.

https://doi.org/10.1182/blood.V108.11.2015.2015

Published: 2006

Journal Articles

Childhood Secondary ALL after ALL Treatment.

Jan Zuna, Cornelia Eckert, Hélène Cavé, Claus Meyer, Björn Schneider, Eva Fronkova, Katerina Muzikova, Denisa Mendelova, Patrick Boutard, André Schrauder, Jaroslav Sterba, Rolf Marschalek, Jan Stary, Jan Trka

Blood (2005) 106 (11): 852.

https://doi.org/10.1182/blood.V106.11.852.852

Published: 2005

Journal Articles

Is CDKN2A +/− CDKN2B and MTAP Inactivation of Prognostic Significance in B-Precursor Childhood Acute Lymphoblastic Leukemia? Results of EORTC Studies 58881 and 58951.

Delphine Mirebeau, MD, Cécile Acquaviva, PharmD, Stefan Suciu, PHD, Raphaëlle Bertin, PharmD, Alain Robert, MD, Patrick Boutard, MD, Françoise Méchinaud, MD, Emmanuel Plouvier, MD, Jacques Otten, MD, Etienne Vilmer, MD, Hélène Cavé, PharmD, PHD

Blood (2004) 104 (11): 1076.

https://doi.org/10.1182/blood.V104.11.1076.1076

Published: 2004

Journal Articles

Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951

Blood (2004) 103 (2): 442–450.

https://doi.org/10.1182/blood-2003-05-1495

Published: 2004

Journal Articles

Treatment outcome in infant acute lymphoblastic leukemia

Blood (2000) 95 (8): 2729.

https://doi.org/10.1182/blood.V95.8.2729

Published: 2000

Journal Articles

Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome

Rémi Letestu, Natacha Vitrat, Aline Massé, Jean-Pierre Le Couedic, Vladimir Lazar, Philippe Rameau, Françoise Wendling, Jacqueline Vuillier, Patrick Boutard, Emmanuel Plouvier, Mireille Plasse, Rémi Favier, William Vainchenker, Najet Debili

Blood (2000) 95 (5): 1633–1641.

https://doi.org/10.1182/blood.V95.5.1633.005k25_1633_1641

Published: 2000

NARROW

Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results

Low CNS Relapse Incidence without Radiotherapy and Improvement of Outcome: Results of Subsequent EORTC-CLG 58881 and 58951 Trials in Pediatric T-Cell Acute Lymphoblastic Leukemia (ALL)

Prolonged E. Coli Asparaginase Therapy Does Not Improve Significantly the Outcome for Children with Low and Average Risk Acute Lymphoblastic Leukemia (ALL) and Non Hodgkin Lymphoma (NHL): Final Report of the EORTC-CLG Randomized Phase III Trial 58951

In Childhood B-Lineage Acute Lymphoblastic Leukemia (B-ALL) with Hyperdiploidy >50 Chromosomes, Patients with 58 to 66 Chromosomes Have 99% EFS At 6-Year Follow-up: Results of the EORTC CLG 58951 Trial

Similar Efficacy and Toxicity Profile for Idarubicine and Mitoxantrone in Induction and Intensification Treatment of Children with Acute Myeloid Leukemia (AML) or Myelodysplasia (MDS): Long-Term Results of the EORTC-CLG Randomized Phase III Trial 58921

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951

Prognostic Significance of NOTCH1 and FBXW7 Mutations in Childhood T-Cell Acute Lymphoblastic Leukemia (T-ALL): Results From the EORTC Children Leukemia Group.

Dexamethasone(DEX)(6mg/sm/d) and Prednisolone(PRED)(60mg/sm/d) in Induction Therapy of Childhood ALL Are Equally Effective: Results of the 2nd Interim Analysis of EORTC Trial 58951

Prognostic Significance of Central Nervous System (CNS) Status of Children with Acute Lymphoblastic Leukemia (ALL) Treated without Cranial Irradiation: Results of European Organization for Research and Treatment of Cancer (EORTC) Children Leukemia Group Study 58951

Improved Outcome with Pulses of Vincristine and Steroids in Continuation Therapy of Children with Average Risk Acute Lymphoblastic Leukemia (ALL) and Non Hodgkin Lymphoma (NHL): Final Report of the EORTC Randomized Phase III Trial 58951

Efficacy of the Combination of Gemtuzumab-Ozogamicin (Mylotarg(R)) and Cytarabine (GOCYT) in Childhood Myeloid Leukemia: A Compassionate Use Based Review in France.

Childhood Secondary ALL after ALL Treatment.

Is CDKN2A +/− CDKN2B and MTAP Inactivation of Prognostic Significance in B-Precursor Childhood Acute Lymphoblastic Leukemia? Results of EORTC Studies 58881 and 58951.

Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951

Treatment outcome in infant acute lymphoblastic leukemia

Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only